Skip to main content
Equibles

RICE HALL JAMES & ASSOCIATES, LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1230765 San Diego, CA
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,578,605
+$451,447 QoQ
Shares Held
183,801
+9.6% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#50
of 172 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RICE HALL JAMES & ASSOCIATES, LLC holds $259,930,953 across 19 Biotechnology names. MLTX ranks #15 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 270,052 $85,360,736
2 ASND
Ascendis Pharma A/S
 148,644 $39,646,327
3 VRDN
Viridian Therapeutics, Inc.\DE
 1,175,906 $21,601,393
4 ACAD
Acadia Pharmaceuticals Inc
 618,887 $15,657,841
5 BMRN
Biomarin Pharmaceutical Inc
 248,224 $14,203,377
6 TSHA
Taysha Gene Therapies, Inc.
 1,992,229 $13,567,079
7 MIRM
Mirum Pharmaceuticals, Inc.
 110,673 $12,956,488
8 URGN
UroGen Pharma Ltd.
 300,650 $11,063,920

All Filings in MLTX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,578,605 183,801
2026-03-31 $3,127,158 167,766
2025-12-31 $1,679,988 127,465
2025-09-30 $966,766 134,835
2025-06-30 $6,717,504 142,320
2025-03-31 $5,372,750 137,516
2024-12-31 $6,017,851 111,133
2024-09-30 $3,805,146 75,469